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Objective:We investigated risk factors for suicidal ideation and behavior among currently
depressed patients with major depressive disorder (MDD), major depressive episode
(MDE) in bipolar disorder (BD), or MDE with comorbid borderline personality disorder
(MDE/BPD). We compared current and lifetime prevalence of suicidal ideation and
behavior, and investigated dimensional measures of BPD or mixed affective features of
the MDE as indicators of risk.
Methods: Based on screening of 1,655 referrals, we recruited 124 psychiatric secondary
care outpatients with MDE and stratified them into three subcohorts (MDD, BD, and MDE/
BPD) using the Structured Clinical Interview for DSM-IV I and II. We examined suicidal
ideation and behavior with the Columbia Suicide Severity Rating Scale (CSSRS). In
addition, we quantified the severity of BPD symptoms and BD mixed features both
categorically/diagnostically and dimensionally (using instruments such as the Borderline
Personality Disorder Severity Index) in two time frames.
Results: There were highly significant differences between the lifetime prevalences of
suicide attempts between the subcohorts, with attempts reported by 16% of the MDD,
30% of the BD, and 60% of the BPD subcohort. Remarkably, the lifetime prevalence of
suicide attempts in patients with comorbid BD and BPD exceeded 90%. The severity of
BPD features was independently associated with risk of suicide attempts both lifetime and
during the current MDE. It also associated in a dose-dependent manner with recent
severity of ideation in both BPD and non-BPD patients. In multinominal logistic regression
models, hopelessness was the most consistent independent risk factor for severe suicidal
ideation in both time frames, whereas younger age and more severe BPD features were
most consistently associated with suicide attempts.g April 2020 | Volume 11 | Article 2901
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Frontiers in Psychiatry | www.frontiersin.orConclusions: Among patients with major depressive episodes, diagnosis of bipolar
disorder, or presence of comorbid borderline personality features both imply remarkably
high risk of suicide attempts. Risk factors for suicidal ideation and suicidal acts overlap,
but may not be identical. The estimated severity of borderline personality features seems
to associate with history of suicidal behavior and current severity of suicidal ideation in
dose-dependent fashion among all mood disorder patients. Therefore, reliable
assessment of borderline features may advance the evaluation of suicide risk.Keywords: suicide, suicide attempt, suicidal ideation, major depressive disorder, bipolar disorder, borderline
personality disorder, Borderline Personality Disorder Severity Index, Columbia Suicide Severity Rating ScaleINTRODUCTION
Patients suffering from mood disorders or borderline personality
disorder (BPD) are at high risk of suicide. According to
psychological autopsy studies, suicide is preceded by
psychiatric disorders in the vast majority (c. 90%) of cases (1,
2). In long-term follow-up studies of patients with bipolar
disorder (BD), major depressive disorder (MDD), and BPD,
suicide mortality is significant (3, 4). Cumulative incidence of
suicide among Danish psychiatric patients over 18 years was 4%
for women and 7% for men with MDD, and 1% higher in BD (5).
The risk of patients with softer BD features, such as periods of
elevated mood of subsyndromal intensity or duration, remains
unclear (6, 7). Previous suicide attempts (SAs) have been
reported in up to half of BD and a third of MDD patients in
psychiatric clinical samples (8). In a prospectively followed
cohort of high-risk BPD patients, one third of the patients
attempted suicide within 24 months (9). Identifying risk
factors for suicidal behavior and ideation in these prevalent
psychiatric disorders remains a research priority.
The suicidal process can be conceptualized as potentially
progressing from ideation to attempt or death. The risk factors
for different stages of suicidal ideation and acts may not be
identical (10), and may differ across diagnostic and demographic
groups (11), as well as temporally (9). Furthermore, effect of
temporally distal risk factors may be mediated by more proximal
clinical factors; e.g., influence of childhood maltreatment may be
mediated by borderline personality features (12). Therefore,
examining putative risk factors across diagnostic groups and
stages of the suicidal process is important.
Established risk factors for suicide death in both MDD and
BD include male gender and a family history of suicide (13–15),
whereas risk factors common for SA include female gender, low
age at onset, a recent depressive episode, comorbid anxiety,
substance use, cluster B personality disorders, and a family
history of suicide (14, 16). The risk of SA in mood disorder
patients is related in a dose-dependent manner to time spent in
depression, most significantly during major depressive episodes
(MDE) (16, 17). Hopelessness is a risk factor for SA at least in
MDD (18). Since BD patients have a lower age at onset and
spend more time unwell than MDD patients, their lifetime risk
for SA is higher (8, 11), and similar mechanisms seem to be at
work in BPD (19). In a mixed sample of MDD and BD patients,g 2features suggestive of at least a propensity towards BD were
overrepresented among attempters (20). In BPD patients,
worsening of comorbid MDD or substance use disorders
(SUDs), childhood sexual abuse, traits of aggression and
affective dysregulation, psychiatric hospitalization, being of a
minority race, or having frequent changes in employment have
been prospectively associated with a higher risk of SA
(21–24).While BPD per se and certain BPD traits have been
noted to be risk factors for SAs in depression, they are rarely
dimensionally assessed, and thus, the importance of severity of
BPD traits for risk of suicidal ideation and behavior
remains unclear.
Although patients with MDD, BD, and BPD are at high risk of
suicidal behavior, few studies have directly compared the
prevalence and risk factors of suicidal ideation and attempts
among these patient groups. Methodologically rigorous studies
examining the association between adequately quantified BPD
symptom/feature severity and suicidal ideation or behavior have
been lacking, and the role of softer bipolar features in suicidal
ideation and behavior is obscure. Such knowledge may help in
identifying the most pertinent risk factors for suicidal behavior
and ideation among mood disorder patients, thus helping in
targeting treatment and preventive efforts.
The aim of this study was to investigate the prevalence and
risk factors of SA among patients with MDE inMDD or BD, with
or without comorbid BPD. Our a priori hypotheses were that (a)
lifetime and recent SA are more prevalent and suicidal ideation
more severe among BD and BPD/MDD patients than among
MDD patients, (b) severe features or symptoms of BPD is a risk
factor for suicidal ideation and behavior, and (c) mixed
symptoms during depressive episodes are correlated with risk
of SA or suicidal ideation.MATERIALS AND METHODS
This was an observational cohort study conducted in Helsinki,
Finland. Our sampling frame consisted of all patients referred
with a possible diagnosis of affective disorder to the Northern
and Eastern psychiatric outpatient clinics (offering secondary
psychiatric care to a population of 234,415 adults).
The study was conducted according to the tenets of the
Declaration of Helsinki (2013). Written informed consent wasApril 2020 | Volume 11 | Article 290
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approved by the Ethics Committee of the Helsinki and
Uusimaa Hospital District, and the research permit was
granted by the City of Helsinki.
Inclusion and Exclusion Criteria
Inclusion criteria were (1) current MDE, (2) a Montgomery-
Åsberg Depression Rating Score (MADRS) ≥ 15, and (3) age 18–
50 years. Exclusion criteria were (1) acute psychotic symptoms,
(2) a diagnosis of schizophrenia or another primary psychotic
disorder (not including MDD or BD with previous psychotic
symptoms), (3) substance dependence (as in DSM-IV) with any
current use, (4) ongoing use of large quantities of alcohol (24
units/week for men and 16 units/week for women) or
benzodiazepine-type drugs ≥ 15 mg/day diazepam equivalents)
in the last month, (5) any use of illicit drugs in the last month
other than sporadic use of cannabis (once monthly in the last
three months), (6) schizotypal or antisocial personality disorder,
(7) a major neurocognitive or neurodevelopmental disorder, and
(8) insufficient proficiency in the Finnish language to participate.
Stratification and Recruitment
The patients were stratified into three principal diagnosis
subcohorts: (1) MDD (no BPD), (2) BD, and (3) BPD with
MDE. In case of comorbid BD and BPD, all BD type I patients
were assigned to the BD subcohort, otherwise subcohort
assignment was by principal clinical diagnosis.
Two of the authors (LS and JS) screened a total of 1,655 referrals
for subjects. We preliminarily stratified these into three recruitment
pools according to likely clinical diagnosis: (1) MDD with current
MDE, (2) probable MDE in BD, and (3) probable MDE with
comorbid BPD, and by gender. We aimed for equal representation
in the strata, enriching currently underrepresented categories. If
necessary, the patient to be interviewed was randomly selected
within the stratum. Of screened referrals, 436 did not meet inclusion
criteria, 855 were not contacted due to limited capacity or not
reached, and 209 declined to participate. Thirty-one patients were
excluded after a clinical interview, leaving a sample of 124 subjects.
These were classified into the three final subcohorts according to
final diagnosis.
Altogether, 31 patients were included in the BPD subcohort,
43 in the BD subcohort, and the remaining 50 in the MDD
subcohort. Of these, 14 patients met the DSM criteria for both
BD (type II) and BPD, eight of these were included in the BPD
and six in the BD subcohort. Fourteen patients (six from the
BPD, three from the BD, and five from the MDD subcohort) did
not complete the Columbia Suicide Severity Rating Scale
(CSSRS) (25) and are not included in the analyses of suicidal
ideation and behavior. These patients did not differ from the
main sample in MADRS scores or reported current suicidal
thoughts or actions in the SCID.
Interviews, Questionnaires, and Inter-
Rater Reliability
All subjects were interviewed using the Structured Clinical
Interview for DSM-IV-TR (SCID-I) (26) and SCID-II (27)
(with the following personality disorders: paranoid,Frontiers in Psychiatry | www.frontiersin.org 3schizotypal, borderline, histrionic, narcissistic, avoidant,
dependent, and obsessive-compulsive), MADRS (28), the
Young Mania Rating Scale (YMRS) (29), Borderline
Personality Disorder Severity Index (BPDSI) (30), part of the
bipolar specifier (31), the Social and Occupational Functioning
Assessment Scale (SOFAS) (32), and the CSSRS (25) in the use of
which the performing authors (LS and JS) had received extensive
training. Subjects were asked to complete questionnaires,
including the Beck Depression Inventory-II (BDI-II) (33), the
Patient Health Questionnaire-9 (PHQ-9) (34), the Overall
Anxiety Severity and Impairment Scale (OASIS) (35), the
McLean Screening Instrument for BPD (MSI-BPD) (36), the
Perceived Social Support Scale (PSSS) (37), and the Beck
Hopelessness Scale (HS) (38). We quantified possible mixed
features of the index MDE via interview, scoring the
occurrence of manic symptoms during the current MDE from
0 to 5 (Mix-MDE, see Supplementary Material for details). The
subjects were met three times. Interrater reliability for principal
diagnoses, tested by rating of videotaped interviews, was
excellent (Cohen's k for MDD 1.0, for bipolar disorder 0.898,
for BPD 0.891).
As per the C-SSRS, we explored the severity of the subjects'
most severe lifetime and recent suicidal ideation. This was
quantified on the Suicidal Ideation Scale (SIS). Suicidal
behavior included preparative acts in addition to aborted and
interrupted and completed attempts (25). We classified our
subjects into the following categories for both most severe
lifetime and recent suicidali ideation: (1) no or mild suicidal
ideation (SIS 0–2); (2) severe ideation (SIS 3–5) without SA, and
(3) SA. For analyzing bipolarity dimensionally, we classified
patients into the following ordinal categories: (1) no evidence
of bipolarity, (2) bipolarity specifier positive but DSM-5 negative
(subsyndromal hypomanias with a duration of 1–3 days only) (6,
7), (3) DSM-5 BD type II, and (4) DSM-5 BD type I. This ordinal
measure was then used as a covariate in statistical analyses.
Statistical Analyses
Data were assembled into a database using SQLite (http://www.
sqlite.org/) and analyzed with IBM SPSS Statistics (https://www.
ibm.com/analytics/us/en/technology/spss/) version 24. Chi-
square test, Fisher's exact test, t-tests, and ANOVA were used
in group comparisons. Furthermore, we analyzed correlates of
suicidal ideation and behavior using multinomial logistic
regression (using the latest available symptom severity scores),
while subtracting suicide-related items from the MADRS, from
the BPDSI, and from the number of positive BPD criteria in the
SCID-II to avoid circularity.
Several multinomial logistic regression models were
compared in assessing risk factors of lifetime and recent
significant suicidal ideation and SA. Because each covariate has
multiple regression coefficients in the multinomial model, overall
significance of a covariate is tested by comparing models with
and without it using a likelihood-ratio test. The covariates used
in the initial lifetime model were gender, age, diagnosis of SUD,
eating disorder, the bipolarity ordinal measure, most recent
MADRS, HS, OASIS, number of positive BPD criteria (except
suicidal ideation or behavior) in the SCID-II, PSSS, and durationApril 2020 | Volume 11 | Article 290
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behavior, the factors used were gender and diagnoses of eating or
substance use disorders, while the covariates were the bipolarity
ordinal measure, age, HS, OASIS, MADRS, BPDSI, Mix-MDE,
PSSS, and duration of illness. Variables that were neither
theoretically central nor statistically significant (i.e., for the
lifetime model diagnosis of eating disorder or SUD, OASIS,
PSSS and duration of illness; for the recent model diagnosis of
eating disorder or SUD, OASIS, PSSS, duration of illness), were
excluded from our final model.RESULTS
No significant differences existed between the three patient
subcohorts in gender, age, severity of depression, hopelessness,
or level of functioning or perceived social support (Table 1). The
severity of borderline symptoms was expectedly significantly
higher in the BPD subcohort, and the YMRS scores lower in
the MDD cohort, than in the others. Most (79%) of the patients
in all subcohorts were treated with pharmacotherapy. However,
they differed in use of mood stabilizers, used by 4%, 26%, and
10%; antipsychotics, used by 10%, 30%, and 16%; and
antidepressants, used by 74% of the MDD, 56% of the BD, and
87% of the BPD subcohorts, respectively.
Prevalence and severity of suicidal behavior and ideation is
reported in Table 2. There were highly significant differences
(p < 0.001) between the subcohorts in the lifetime prevalences of
suicide attempts, suicidal behavior, and non-suicidal self-injury,
all of which were most common in the BPD subcohort (in which
they were reported by the majority of subjects). The median SISFrontiers in Psychiatry | www.frontiersin.org 4for most severe lifetime suicidal ideation was 4 in the BPD
subcohort and 3 in the others, and there were also significant
differences between the subcohorts in the lifetime prevalence of
significant suicidal ideation (p = 0.001), whereas the inter-
subcohort differences in the prevalence of any suicidal ideation
did not reach statistical significance (p = 0.066). During the
preceding month the corresponding median SIS scores were 4
(the BPD subcohort) and 1 (others).
When grouping patients purely into four groups by MDD/BD
and BPD-diagnosis status (instead of by subcohorts) there were
significant differences in the lifetime prevalences of SA (Fisher's
exact test, p < 0.001), with earlier SA reported by 15.6% of MDD
patients without comorbid BPD, 25.0% of BD patients without
BPD, 44.4% of MDD patients with comorbid BPD, and 90.9%
(10 out of 11) among BD patients with comorbid BPD
(Figure 1).
The multinominal regression model for lifetime suicidal
behavior and ideation explained these phenomena with high
statistical significance (2LL = 184.013; c2 (12) = 42.635; p <
0.001), and a moderate effect size (Nagelkerke pseudo-R2 =
0.368, Table 3). The covariates that significantly contributed to
the model were age (p= 0.040), MADRS (p = 0.003), HS (p =
0.019), and number of positive BPD criteria (p = 0.004), but not
the bipolarity measure (p = 0.346) or gender (p = 0.151).
The recent suicidal behavior and ideation model was also
highly significant (-2LL = 149.186; c2 (14) = 44.670; p < 0.001),
and the effect size moderate (Nagelkerke pseudo-R2 = 0.403,
Table 4). Age (p = 0.009), HS (p = 0.010), MADRS (p = 0.013),
and BPDSI (p < 0.001) were significant contributors to this
overall model, while gender (p=0.552), the bipolarity ordinal
measure (p = 0.984), and Mix-MDE (p = 0.502) were not.TABLE 1 | Sociodemographic and clinical characteristics by subcohort.
Subcohort
MDD Bipolar Disorder BPD Total
Count %/Mean SD Count %/Mean SD Count %/Mean SD Count %/Mean SD Sig.
Sex Male 21 42.0% 12 27.9% 8 25.8% 41 33.1% 0.237a)
Female 29 58.0% 31 72.1% 23 74.2% 83 66.9%
Age 31.4 10.2 31.6 9.1 28.5 7.6 30.8 9.2 0.301b)
Bipolar Disorder Total 0 0.0% 43 100.0% 8 25.8% 51 41.1% <0.001a)
Type II 0 0.0% 33 76.7% 8 25.8% 41 33.1%
Type I 0 0.0% 10 23.3% 0 0.0% 10 8.1%
BPD 0 0.0% 6 14.0% 31 100.0% 37 29.8% <0.001a)
SUD 4 8.0% 19 44.2% 14 45.2% 37 29.8% <0.001a)
Anxiety disorder 37 74.0% 34 79.1% 29 93.5% 100 80.6% 0.095a)
Eating disorder 10 20.0% 13 30.2% 10 32.3% 33 26.6% 0.405a)
MADRS 25.0 6.0 25.2 6.9 26.3 6.0 25.4 6.3 0.639b)
BDI-II 28.7 10.1 30.6 10.7 33.6 9.8 30.6 10.3 0.166b)
YMRS 1.7 2.7 3.4 3.7 3.5 2.6 2.8 3.2 0.007b)
OASIS 11.8 3.1 12.6 3.7 12.9 4.6 12.3 3.7 0.419b)
HS 12.5 3.9 11.8 4.8 10.9 3.9 11.9 4.2 0.287b)
PSSS 40.0 13.1 45.0 11.6 40.0 11.6 42.0 12.4 0.154b)
SOFAS 56.2 11.6 57.4 13.0 60.0 10.7 57.5 11.9 0.446b)
BPDSI 14.4 8.3 16.8 6.6 20.8 13.8 16.8 9.7 0.013b)April 2020 | Volume 11 | Aa)Pearson c2.
b)One way ANOVA.
BDI2, Beck depression inventory 2; BPD, Borderline personality disorder; BPDSI, Borderline personality disorder severity index; HS, Hopelessness scale; MADRS, Montgomery Åsberg
Depression Rating Scale; MDD, Major depressive disorder; PSSS, Perceived social support scale; SOFAS, Social and occupational functioning assessment scale; SUD, Substance use
disorder; YMRS, Young mania rating scale.rticle 290
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suicidal ideation and BPDSI scores (Pearson correlation: 0.383,
p < 0.001), which remained significant both among BPD
(Pearson correlation: 0.586, p < 0.001) and non-BPD patients
(Pearson correlation: 0.278, p = 0.012).
As a post-hoc analysis, we replaced the total BPDSI score in
the multinomial regression model for recent suicidal behavior
and ideation with the BPDSI subscores (except the self-injury
category). The model was significant (p > 0.001). Of the BPDSI
subcategories, sensitivity to abandonment (p = 0.004, OR =
2.070, 95% CI [1.264 - 3.391]) and anger/rage conferred
increased odds of having made an attempt (p = 0.007, OR =
2.719, 95% CI [1.318 - 5.611]); the others did not reach
statistical significance.Frontiers in Psychiatry | www.frontiersin.org 5DISCUSSION
In this observational clinical study of treatment-seeking major
depressive patients, we investigated the prevalence of and risk
factors for suicidal ideation and attempts. We compared
depressed patients with MDD, BD, and/or BPD. As
hypothesized, we found marked differences in the lifetime
prevalence of suicide attempts, which was twofold in the BD
and fourfold in the BPD/MDE subcohort compared with MDD
patients. Severity of BPD features was also strongly associated
with suicidal ideation, both recently and over the lifetime.
However, we did not find mixed symptoms during the index
MDE to be a risk factor for suicidal behavior and ideation in this
cross-sectional and retrospective analysis.FIGURE 1 | Lifetime prevalence of suicide attempts by diagnostic group.TABLE 2 | Prevalence and severity of suicidal behavior and ideation.
Subcohort
MDD Bipolar Disorder BPD Total
Count %/Mean SD Count %/Mean SD Count %/Mean SD Count %/Mean SD Sig.
Lifetime Attempts 7 15.6% – 12 30.0% – 15 60.0% – 34 30.9% – <0.001a)
Behaviour 12 26.7% – 16 40.0% – 20 80.0% – 48 43.6% – <0.001a)
Non-suicidal self injury 6 22.5% – 9 22.5% – 16 64.0% – 31 28.2% – <0.001a)
Ideation 39 86.7% – 32 80.0% – 25 100.0% – 96 87.3% – 0.066a)
Significant ideation 31 68.9% – 24 60.0% – 25 100.0% – 80 72.7% – 0.001a)
SIS 3.00 1.68 2.68 1.86 4.08 0.76 3.13 1.67 0.003b)
SIIR 13.02 17.07 12.28 7.19 15.84 3.00 13.39 6.52 0.088b)
Recent Attempts 3 6.7% – 2 5.0% – 5 20.0% – 10 9.1% – 0.138c)
Behaviour 8 17.8% – 4 10.0% – 8 32.0% – 20 18.2% – 0.097c)
Non-suicidal self injury 3 6.7% – 6 15.0% – 9 36.0% – 18 16.4% – 0.008c)
Ideation 29 64.4% – 21 52.5% – 18 72.0% – 68 61.8% – 0.278a)
Significant ideation 16 35.6% – 11 27.5% – 13 52.0% – 40 36.4% – 0.124a)
SIS 1.76 1.80 1.25 1.48 2.04 1.65 1.64 1.67 0.147b)
SIIR 8.13 7.20 6.90 7.08 9.08 5.97 7.90 6.89 0.447b)April 2020 | Volume 11 | Aa)Pearson c2.
b)One-Way ANOVA.
c)Fisher's exact test.
BPD, Borderline personality disorder; MDD, Major depressive disorder; SIS, Suicidal ideation scale; SIIR, Suicidal ideation intensity rating.rticle 290
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Strengths of this study include the comparison of three clinically
and epidemiologically central diagnostic groups with a high suicide
risk, the representativeness of recruitment by stratified sampling, the
standardized and rigorous assessment of dimensional aspects of
psychiatric pathology such as BPD and suicidal ideation and
behavior with the BPDSI and the CSSRS, the excellent inter-rater
reliability, and the analysis of our results in two time frames (current
and lifetime). Our main limitations include moderate sample size,
retrospective evaluations, and unknown inter-rater reliability of the
BPDSI. Features of our study relevant for interpretation and
generalizability of the findings include the observational design,Frontiers in Psychiatry | www.frontiersin.org 6i.e., treatments provided were not controlled by the researchers, age
range 18–50 years, and deliberate focus on proximal, rather than
temporally distal, risk factors.
Suicidal Behavior
We found marked differences in suicidal behavior and ideation of
the patient groups. Approximately one-third of patients reported an
earlier SA, which is in line with earlier Finnish studies of patients
with mood disorders (39).The proportion of patients in the MDD
subcohort reporting a history of earlier SA was 15%, comparable
with the findings of STAR*D and iSpot-D (40, 41) as well as with
other Finnish studies (42). Relative to the MDD subcohort, in theTABLE 4 | Recent suicidal idation/behavior - multinominal logistic regression models.
Uncontrolled Controlled
B ORb) 95% CI Sig. B ORb) 95% CI Sig.
Significant ideation, no attempt Bipolarity Ordinal -0.076 0.927 0.631 1.360 0.697 0.045 1.046 0.643 1.701 0.856
Age -0.029 0.971 0.926 1.018 0.226 -0.082 0.921 0.862 0.984 0.015
HS 0.137 1.147 1.038 1.267 0.007 0.181 1.199 1.058 1.358 0.004
MADRS 0.130 1.139 1.051 1.235 0.002 0.135 1.145 1.038 1.263 0.007
BPDSI 0.103 1.108 1.044 1.177 0.001 0.134 1.144 1.057 1.237 0.001
Mix-MDE 0.002 1.002 0.945 1.062 0.950 -0.050 0.951 0.869 1.041 0.274
Male sex 0.218 1.243 0.525 2.942 0.620 0.612 1.844 0.633 5.375 0.262
Attempt Bipolarity Ordinal -0.110 0.896 0.482 1.663 0.727 0.026 1.026 0.486 2.167 0.947
Age -0.086 0.918 0.836 1.008 0.073 -0.112 0.894 0.804 0.994 0.039
HS 0.010 1.010 0.877 1.164 0.885 0.090 1.094 0.928 1.290 0.286
MADRS 0.089 1.093 0.970 1.232 0.143 0.110 1.116 0.979 1.274 0.101
BPDSI 0.125 1.133 1.038 1.237 0.005 0.136 1.146 1.029 1.277 0.013
Mix-MDE 0.029 1.029 0.945 1.121 0.507 -0.042 0.959 0.846 1.087 0.514
Male sex -0.199 0.820 0.194 3.472 0.787 0.174 1.190 0.241 5.870 0.831April 2020 | Volume 11 | ArticThe model explained suicidality statistically significantly (-2LL = 149.186; c2 (14) = 44.670; p < 0.001), and a moderate effect size (Nagelkerke pseudo-R2 = 0.403). The model fit was good
and resulted in statistically similar predicted and observed suicidality distributions(Pearson p = 0.324, deviance p = 0.999).
a)The reference category is: No or mild ideation (SIS 0-2).
b)OR equals Exp(B).
BPDSI, Borderline personality disorder severity index; HS, Hopelessness scale; MADRS, Montogomery Åsberg Depression Rating Scale; Mix-MDE, Mixed symptoms during major
depressive episode; OR, Odds ratio; SIS, Suicidal ideation scale.TABLE 3 | Most severe lifetime suicidal ideation/behavior - Multinominal logistic regression models.
Suicidalitya) Uncontrolled Multiple (adjusted) regression
B ORb) 95% CI Sig. B ORb) 95% CI Sig.
Significant ideation, no attempt Age -0.032 0.969 0.914 1.027 0.291 -0.043 0.957 0.891 1.028 0.234
Bipolarity Ordinal -0.360 0.698 0.419 1.161 0.166 -0.399 0.671 0.389 1.157 0.151
MADRS -0.008 0.992 0.894 1.100 0.874 0.043 1.044 0.932 1.170 0.455
HS 0.105 1.111 0.987 1.249 0.080 0.140 1.150 1.002 1.321 0.047
Nr of pos. BPD criteria 0.045 1.046 0.974 1.124 0.218 0.268 1.307 0.943 1.813 0.108
Sex (male) 1.190 3.286 1.025 10.528 0.045 1.223 3.396 0.957 12.051 0.059
Attempt Age -0.052 0.949 0.903 0.997 0.016 -0.081 0.922 0.864 0.985 0.018
Bipolarity Ordinal -0.137 0.872 0.584 1.303 0.396 -0.213 0.808 0.495 1.321 0.443
MADRS 0.090 1.094 1.005 1.192 0.003 0.154 1.166 1.053 1.291 0.003
HS 0.125 1.133 1.027 1.252 0.009 0.170 1.185 1.044 1.345 0.009
Nr of pos. BPD criteria 0.080 1.083 1.018 1.152 0.003 0.461 1.586 1.172 2.146 0.001
Sex (male) 0.602 1.825 0.667 4.998 0.201 0.786 2.194 0.658 7.312 0.190The model explained suicidality statistically significantly (-2LL = 184.013; c2 (12) = 42.635; p < 0.001) with a moderate effect size (Nagelkerke pseudo-R2 = 0.368). The model fit was good
and resulted in statistically similar predicted and observed suicidality distributions (Pearson and deviance statistic yielded p = 0.185 and p = 0.862, respectively).
a)The reference category is: No or mild ideation (SIS 0-2).
b)OR equals Exp(B).
BPD, Borderline personality disorder; HS, Hopelessness scale; MADRS, Montogomery Åsberg Depression Rating Scale; OR, Odds ratio; SIS, Suicidal ideation scale.le 290
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lower than previous reports of around 40%) (43, 44) and in the BPD
subcohort four times more prevalent (60%). Remarkably, over 90%
of BD patients with comorbid BPD reported a previous SA, which
may indicate cumulative risk, although this finding is in need of
replication. Suicide attempts during the index MDE were reported
by approximately 9% of patients, which is somewhat lower than in
previous Finnish studies of MDD (42) and BD patients, which
however, included inpatients. The fact that lifetime, but not recent,
prevalence of SA was higher in the BD than in the MDD subcohort
is in line with earlier evidence that the increased SA risk of BD
patients (relative to MDD patients) is due to their spending more
time unwell. Our findings suggest that BD patients have a twofold
higher risk of SA than MDD patients, MDD/BPD patients have a
twofold higher risk than BD patients, and the risk is cumulative in
BD/BPD patients, with the risk being six-fold higher than in MDD
patients without BPD.
Suicidal Ideation
Suicidal ideation is a multifaceted concept, and how much of it is
found in a particular sample depends on both how the concept is
defined and the tools with which it is measured (45). The CSSRS,
which is aimed to capture a wide range of suicidal ideation in a
precise manner, indicated some degree of suicidal ideation in the
vast majority (87.3%) of our sample. This is a larger proportion
than in many previous studies (39) probably indicating a greater
sensitivity of the instrument used, although our sampling
procedure, which aimed to include sufficient numbers of BPD
patients, may also have contributed. Recent suicidal ideation was
reported by approximately 60% of BD and MDD patients,
comparable to earlier BD (44) and MDD studies (42) As well
as being more common, suicidal ideation was also more severe in
the BPD subcohort; the median patient in the BPD group
reported having had suicidal thoughts with specific methods
and some intent to act, whereas median patients in the other
subcohorts did not report ever having had suicidal intent. Our
findings indicate that BPD/MDE patients have a propensity
towards more severe suicidal ideation than other mood
disorder patients, and that having had suicidal intent is
common in this patient group.
Risk Factors and Correlations
We examined risk factors for suicidal ideation and attempts, and
expectedly found that hopelessness was independently correlated
with lifetime risk of previous attempts and severe suicidal ideation,
whereas lower age, increased severity of depressive symptoms, and
features of BPD were correlated with a higher risk of previous SA. A
younger age and more severe features of BPD were independently
correlated with a higher risk of both recent attempts and severe
ideation, whereas hopelessness and severity of depressive symptoms
were related only to the risk of having severe suicidal ideation.
We found that severity of BPD features was independently
correlated with suicidal ideation and acts and related to recent
severity of suicidal ideation in a dose-dependent manner. To our
knowledge, this is the first study to analyze the role of current
severity of BPD features, reliably measured by the BPDSI, as a risk
factor for suicidal behavior and ideation. According to post-hocFrontiers in Psychiatry | www.frontiersin.org 7analyses, sensitivity to abandonment, feelings of emptiness, and
outbursts of anger or rage may be significantly correlated with
significant suicidal ideation or behavior.
In contrast to our hypotheses, we could not confirm earlier
reports of a correlation between bipolar mixed states and either
suicidal ideation or behavior. Some reasons for this may be our
inclusion criterion of current MDE, which may have selected
against mixed states, and the lack of precise information
regarding the affective states of patients at the time of
previous attempts.
Conclusions
In conclusion, we found marked differences in the prevalence
and severity of suicidal ideation and behavior between depressed
patients with MDD, BD, or BPD with MDD. The lifetime
prevalence of suicidal attempts and other behavior was higher
in the BD than in the MDD subcohort, but highest in the BPD/
MDD subcohort. BD with comorbid BPDmay confer an additive
and thus remarkably high risk of suicide attempts. Of all risk
factors examined, dimensional measures of BPD severity were
most consistently and significantly correlated with the risk for
significant ideation and recent SAs. In the light of this study,
severity of BPD features is a central modifiable (46, 47) risk factor
for suicidal behavior and ideation among mood disorder
patients. Thus, measuring this severity reliably (e.g., with the
BPDSI) should be implemented in future suicidological research.
Clinically, assessment of borderline features may advance
evaluation of suicide risk, and their treatment help
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